Rowinsky K. Eric's most recent trade in Biogen Inc was a trade of 2,370 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 2,370 | 24,339 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 8,333 | 16,666 (0%) | 0% | 0 | Common Stock | |
| Biogen Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 21,969 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 8,333 | 8,333 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 12,572 | 12,572 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Eric K. Rowinsky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 4,166 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Eric K. Rowinsky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 2,157 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Eric K. Rowinsky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 2,083 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Eric K. Rowinsky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 2,083 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Eric K. Rowinsky | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 2,083 | 0 | - | - | Stock Option (right to buy) | |
| Biogen Inc | Rowinsky K. Eric | Director | Purchase of securities on an exchange or from another person at price $ 222.54 per share. | 15 Feb 2024 | 455 | 20,629 (0%) | 0% | 222.5 | 101,256 | Common Stock |
| Fortress Biotech Inc | Eric Rowinsky K. | Director | 01 Jan 2024 | 6,666 | 68,797 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | ||
| Biogen Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 20,174 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Fortress Biotech Inc | Eric K. Rowinsky | Director | 10 Feb 2023 | 11,976 | 931,976 (1%) | 0% | 0.8 | 10,000 | COMMON STOCK, PAR VALUE $0.001 | |
| Fortress Biotech Inc | Eric K. Rowinsky | Director | 01 Jan 2023 | 100,000 | 920,000 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | ||
| Biogen Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 19,214 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Fortress Biotech Inc | Eric K. Rowinsky | Director | 01 Jan 2022 | 100,000 | 820,000 (1%) | 0% | 0 | Common Stock, par value $0.001 | ||
| Biogen Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 17,844 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Eric K. Rowinsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) |